O
INSM icon

OrbiMed’s Insmed INSM Stock Holding History

OrbiMed’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-200,000
Closed -$1.97M – 145
2016
Q2 		$1.97M Buy
+200,000
New +$2.33M 0.02% 121

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OrbiMed's INSM Position: Q1 2026 in Review

OrbiMed sold out of Insmed (INSM) in Q1 2026, closing a stake of 25,400 shares — an estimated $4.42M sold.

OrbiMed first reported a position in INSM in Q2 2014 and held it in 22 quarters. The position peaked at $84.2M in Q1 2017. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • OrbiMed reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • OrbiMed sold 25,400 Insmed shares in Q1 2026, an estimated $4.42M.
  • OrbiMed first reported a position in Insmed in Q2 2014 and held it in 22 quarters.
  • OrbiMed's Insmed position peaked at $84.2M in Q1 2017.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.